FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Two People Climb to the Top of Empire State Building Antenna, Fly Banner with Message

Coalition of 25 states sues Trump admin over Medicaid work rule designed to prevent fraud

Internal emails expose how July 4th bash is being derailed by Dem-run county: ‘Offensive’

Michelle Obama Went ‘Absolutely Ballistic’ and Blocked RFK Jr.’s Wife Cheryl Hines from Appearing in New Show: Report

McConnell was found ‘unconscious’ in home last month as condition remains unknown

Congressman Gets Mixed Response After Explaining Why He Disappeared for Four Months

Fox News Poll: A close Senate contest is brewing in Iowa

SEE IT: Trump rides Freedom Train to Theodore Roosevelt Presidential Library ahead of grand opening

Meet the Poster Child for Why Birthright Citizenship Is Horrible: Rep. Ramirez – Born to an Illegal and Now Trashes America and Supporters Terrorists

Jayapal tells murder victims’ parents Congress has other things to do

West Coast state sheriff’s bait bike sting snares dozens of alleged thieves in just months

Mamdani walks back plan to increase NYPD headcount following DSA pressure

Road to America 250 starts with Ford: Exhibit at Union Station shows off iconic vehicles

Government watchdog targets ‘weapons of mass reproduction’ after Supreme Court ruling

Court keeps ‘Decoy Dan’ on Alaska ballot as expert warns ranked-choice system creates voter ‘traps’

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”